| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dATP binding | 1.73e-04 | 5 | 84 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 2.59e-04 | 6 | 84 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 3.62e-04 | 7 | 84 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | deoxyribonucleotide binding | 6.18e-04 | 9 | 84 | 2 | GO:0032552 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 6.18e-04 | 9 | 84 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | cobalamin binding | 7.70e-04 | 10 | 84 | 2 | GO:0031419 | |
| MousePheno | abnormal proximal-distal axis patterning | 4.42e-05 | 13 | 77 | 3 | MP:0001705 | |
| MousePheno | abnormal polar trophectoderm morphology | 6.05e-05 | 39 | 77 | 4 | MP:0012056 | |
| MousePheno | abnormal ectoplacental cone morphology | 6.05e-05 | 39 | 77 | 4 | MP:0005032 | |
| Domain | TF_fork_head_CS_2 | 4.75e-11 | 46 | 90 | 8 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 5.71e-11 | 47 | 90 | 8 | IPR018122 | |
| Domain | FH | 8.12e-11 | 49 | 90 | 8 | SM00339 | |
| Domain | FORK_HEAD_1 | 8.12e-11 | 49 | 90 | 8 | PS00657 | |
| Domain | FORK_HEAD_2 | 8.12e-11 | 49 | 90 | 8 | PS00658 | |
| Domain | Fork_head_dom | 8.12e-11 | 49 | 90 | 8 | IPR001766 | |
| Domain | FORK_HEAD_3 | 8.12e-11 | 49 | 90 | 8 | PS50039 | |
| Domain | Forkhead | 8.12e-11 | 49 | 90 | 8 | PF00250 | |
| Domain | GOLGA6L | 7.51e-09 | 6 | 90 | 4 | IPR026737 | |
| Domain | GOLGA2L5 | 1.89e-08 | 18 | 90 | 5 | PF15070 | |
| Domain | Golgin_A | 1.89e-08 | 18 | 90 | 5 | IPR024858 | |
| Domain | WHTH_DNA-bd_dom | FOXN1 FOXD4L4 FOXD4L3 KAT8 TFDP3 FOXD4L6 FOXJ3 FOXD4L5 FOXD4 FOXI1 | 2.56e-07 | 242 | 90 | 10 | IPR011991 |
| Domain | - | FOXN1 FOXD4L4 FOXD4L3 TFDP3 FOXD4L6 FOXJ3 FOXD4L5 FOXD4 FOXI1 | 1.06e-06 | 218 | 90 | 9 | 1.10.10.10 |
| Domain | Ig_I-set | 3.76e-06 | 190 | 90 | 8 | IPR013098 | |
| Domain | I-set | 3.76e-06 | 190 | 90 | 8 | PF07679 | |
| Domain | IGc2 | 1.78e-05 | 235 | 90 | 8 | SM00408 | |
| Domain | Ig_sub2 | 1.78e-05 | 235 | 90 | 8 | IPR003598 | |
| Domain | DUF3523 | 6.87e-05 | 3 | 90 | 2 | PF12037 | |
| Domain | DUF3523 | 6.87e-05 | 3 | 90 | 2 | IPR021911 | |
| Domain | fn3 | 1.32e-04 | 162 | 90 | 6 | PF00041 | |
| Domain | FN3 | 2.72e-04 | 185 | 90 | 6 | SM00060 | |
| Domain | FN3 | 4.02e-04 | 199 | 90 | 6 | PS50853 | |
| Domain | FN3_dom | 5.21e-04 | 209 | 90 | 6 | IPR003961 | |
| Domain | TPR_1 | 9.39e-04 | 90 | 90 | 4 | PF00515 | |
| Domain | TPR_1 | 9.39e-04 | 90 | 90 | 4 | IPR001440 | |
| Domain | IG | 9.64e-04 | 421 | 90 | 8 | SM00409 | |
| Domain | Ig_sub | 9.64e-04 | 421 | 90 | 8 | IPR003599 | |
| Domain | STI1 | 1.01e-03 | 10 | 90 | 2 | SM00727 | |
| Domain | STI1_HS-bd | 1.01e-03 | 10 | 90 | 2 | IPR006636 | |
| Domain | TPR_REGION | 1.22e-03 | 165 | 90 | 5 | PS50293 | |
| Domain | TPR | 1.22e-03 | 165 | 90 | 5 | PS50005 | |
| Domain | TPR_8 | 2.13e-03 | 53 | 90 | 3 | PF13181 | |
| Domain | ig | 2.26e-03 | 190 | 90 | 5 | PF00047 | |
| Domain | Immunoglobulin | 2.26e-03 | 190 | 90 | 5 | IPR013151 | |
| Domain | IG_LIKE | 2.54e-03 | 491 | 90 | 8 | PS50835 | |
| Domain | Ig-like_dom | 2.94e-03 | 503 | 90 | 8 | IPR007110 | |
| Domain | TPR | 3.51e-03 | 129 | 90 | 4 | SM00028 | |
| Domain | - | 4.63e-03 | 663 | 90 | 9 | 2.60.40.10 | |
| Domain | PH | 5.01e-03 | 229 | 90 | 5 | PF00169 | |
| Pubmed | A genetic study of the suppressors of the Engrailed-1 cerebellar phenotype. | 5.98e-13 | 13 | 95 | 6 | 16884697 | |
| Pubmed | 5.98e-13 | 13 | 95 | 6 | 7957066 | ||
| Pubmed | Neural transcription factors bias cleavage stage blastomeres to give rise to neural ectoderm. | 8.18e-13 | 6 | 95 | 5 | 27092474 | |
| Pubmed | 2.77e-12 | 16 | 95 | 6 | 10208738 | ||
| Pubmed | The mouse fkh-2 gene. Implications for notochord, foregut, and midbrain regionalization. | 7.60e-12 | 8 | 95 | 5 | 8530406 | |
| Pubmed | An amphioxus winged helix/forkhead gene, AmphiFoxD: insights into vertebrate neural crest evolution. | 1.71e-11 | 9 | 95 | 5 | 12412011 | |
| Pubmed | 2.61e-10 | 5 | 95 | 4 | 12234674 | ||
| Pubmed | Six members of the mouse forkhead gene family are developmentally regulated. | 4.02e-10 | 15 | 95 | 5 | 7689224 | |
| Pubmed | 4.02e-10 | 15 | 95 | 5 | 22045912 | ||
| Pubmed | Expression of the winged helix genes fkh-4 and fkh-5 defines domains in the central nervous system. | 5.83e-10 | 16 | 95 | 5 | 8861101 | |
| Pubmed | Functional equivalency between Otx2 and Otx1 in development of the rostral head. | 1.54e-09 | 19 | 95 | 5 | 9895322 | |
| Pubmed | 2.05e-09 | 20 | 95 | 5 | 12812790 | ||
| Pubmed | 2.69e-09 | 21 | 95 | 5 | 9449667 | ||
| Pubmed | 3.47e-09 | 22 | 95 | 5 | 17389379 | ||
| Pubmed | Otx2 is required to respond to signals from anterior neural ridge for forebrain specification. | 5.58e-09 | 24 | 95 | 5 | 11820816 | |
| Pubmed | 5.58e-09 | 24 | 95 | 5 | 29992973 | ||
| Pubmed | Ssdp1 regulates head morphogenesis of mouse embryos by activating the Lim1-Ldb1 complex. | 8.59e-09 | 26 | 95 | 5 | 15857913 | |
| Pubmed | Analysis of the DNA sequence and duplication history of human chromosome 15. | 1.03e-08 | 56 | 95 | 6 | 16572171 | |
| Pubmed | 1.54e-08 | 29 | 95 | 5 | 22972626 | ||
| Pubmed | Genome-scale study of transcription factor expression in the branching mouse lung. | 1.15e-06 | 67 | 95 | 5 | 22711520 | |
| Pubmed | MISP ATAD3B SBF1 NRCAM COPA KRT19 ATAD3A SYNE1 ITSN1 ST13P5 ST13 THRAP3 CNTN2 ALDH7A1 PRRC2B MAPK8IP3 | 1.59e-06 | 1431 | 95 | 16 | 37142655 | |
| Pubmed | HeyL regulates the number of TrkC neurons in dorsal root ganglia. | 3.21e-06 | 11 | 95 | 3 | 19631204 | |
| Pubmed | 3.21e-06 | 11 | 95 | 3 | 12421752 | ||
| Pubmed | A role for Nr-CAM in the patterning of binocular visual pathways. | 4.27e-06 | 12 | 95 | 3 | 16701205 | |
| Pubmed | Pioneering axons regulate neuronal polarization in the developing cerebral cortex. | 5.54e-06 | 13 | 95 | 3 | 24559674 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 28259553 | ||
| Pubmed | SCF(beta-TrCP1) controls Smad4 protein stability in pancreatic cancer cells. | 7.38e-06 | 2 | 95 | 2 | 15855639 | |
| Pubmed | Molecular characterization of the tumor-associated antigen AAA-TOB3. | 7.38e-06 | 2 | 95 | 2 | 16909202 | |
| Pubmed | St13 protects against disordered acinar cell arachidonic acid pathway in chronic pancreatitis. | 7.38e-06 | 2 | 95 | 2 | 35562743 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 18639545 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 12182881 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 17210950 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 25373906 | ||
| Pubmed | 8.18e-06 | 263 | 95 | 7 | 20932939 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | COL5A1 ATAD3B CDH26 HIVEP2 PTPRB TECPR2 ATAD3A OBSCN KIAA1328 TTC17 PAN3 FOXJ3 THRAP3 ARAP1 MAPK8IP3 | 1.22e-05 | 1489 | 95 | 15 | 28611215 |
| Pubmed | O-GlcNAc stabilizes SMAD4 by inhibiting GSK-3β-mediated proteasomal degradation. | 2.21e-05 | 3 | 95 | 2 | 33199824 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 16865698 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 28549128 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 8586965 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 22664726 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 11329126 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 38923254 | ||
| Pubmed | ATAD3A has a scaffolding role regulating mitochondria inner membrane structure and protein assembly. | 2.21e-05 | 3 | 95 | 2 | 34936866 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 25375035 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 18974039 | ||
| Pubmed | Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer. | 2.21e-05 | 3 | 95 | 2 | 30109253 | |
| Pubmed | [ATAD3, a vital membrane-bound mitochondrial ATPase involved in tumor progression]. | 2.21e-05 | 3 | 95 | 2 | 22192748 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 18602664 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 21205796 | ||
| Pubmed | Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2. | 2.21e-05 | 3 | 95 | 2 | 15314162 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 9049255 | ||
| Pubmed | Diverse fates of paralogs following segmental duplication of telomeric genes. | 2.93e-05 | 22 | 95 | 3 | 15233989 | |
| Pubmed | 3.83e-05 | 24 | 95 | 3 | 33722704 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXN1 FOXD4L4 NR1I2 HIVEP2 HEY1 FOXD4L3 TFDP3 FOXJ3 SMAD4 FOXD4 FOXI1 | 3.84e-05 | 908 | 95 | 11 | 19274049 |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 36736924 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 38250153 | ||
| Pubmed | Smad4 protein stability is regulated by ubiquitin ligase SCF beta-TrCP1. | 4.41e-05 | 4 | 95 | 2 | 14988407 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 26022109 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 22814818 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 18986983 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 12139915 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 18177377 | ||
| Pubmed | ATAD3A oligomerization promotes neuropathology and cognitive deficits in Alzheimer's disease models. | 4.41e-05 | 4 | 95 | 2 | 35236834 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 29242539 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 20427667 | ||
| Pubmed | C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions. | 5.51e-05 | 27 | 95 | 3 | 29420262 | |
| Pubmed | 5.55e-05 | 148 | 95 | 5 | 35676246 | ||
| Pubmed | 7.34e-05 | 371 | 95 | 7 | 15747579 | ||
| Pubmed | Liver X receptors are required for thymic resilience and T cell output. | 7.34e-05 | 5 | 95 | 2 | 32716519 | |
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 11807022 | ||
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 29898916 | ||
| Pubmed | Expression analysis of ATAD3 isoforms in rodent and human cell lines and tissues. | 7.34e-05 | 5 | 95 | 2 | 24239551 | |
| Pubmed | Vertebrate Dynein-f depends on Wdr78 for axonemal localization and is essential for ciliary beat. | 7.34e-05 | 5 | 95 | 2 | 30060180 | |
| Pubmed | 8.40e-05 | 31 | 95 | 3 | 29099309 | ||
| Pubmed | 8.40e-05 | 31 | 95 | 3 | 21300867 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 9.69e-05 | 268 | 95 | 6 | 33024031 | |
| Pubmed | Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. | 1.07e-04 | 89 | 95 | 4 | 27034005 | |
| Pubmed | Generation of an inducible colon-specific Cre enzyme mouse line for colon cancer research. | 1.10e-04 | 6 | 95 | 2 | 27708166 | |
| Pubmed | 1.10e-04 | 6 | 95 | 2 | 8825632 | ||
| Pubmed | 1.10e-04 | 6 | 95 | 2 | 29069604 | ||
| Pubmed | New loci associated with central cornea thickness include COL5A1, AKAP13 and AVGR8. | 1.10e-04 | 6 | 95 | 2 | 20719862 | |
| Pubmed | Mammalian SAD kinases are required for neuronal polarization. | 1.10e-04 | 6 | 95 | 2 | 15705853 | |
| Pubmed | 1.10e-04 | 6 | 95 | 2 | 10409510 | ||
| Pubmed | 1.10e-04 | 6 | 95 | 2 | 31472450 | ||
| Pubmed | FOXD4L4 HIVEP2 HEY1 FOXD4L3 TFDP3 FOXD4L6 FOXJ3 FOXD4L5 FOXD4 | 1.43e-04 | 709 | 95 | 9 | 22988430 | |
| Pubmed | 1.54e-04 | 7 | 95 | 2 | 15561438 | ||
| Pubmed | Differential roles of Netrin-1 and its receptor DCC in inferior olivary neuron migration. | 1.54e-04 | 7 | 95 | 2 | 19409494 | |
| Pubmed | 1.81e-04 | 40 | 95 | 3 | 31152445 | ||
| Pubmed | 1.88e-04 | 103 | 95 | 4 | 10574462 | ||
| Pubmed | 1.95e-04 | 41 | 95 | 3 | 19878569 | ||
| Pubmed | HIVEP2 RBFOX3 NRCAM COPA TTC28 HEY1 SYNE1 ITSN1 TTC17 ST13 BTRC MAPK8IP3 | 1.99e-04 | 1285 | 95 | 12 | 35914814 | |
| Pubmed | 1.99e-04 | 306 | 95 | 6 | 18973680 | ||
| Pubmed | 2.05e-04 | 8 | 95 | 2 | 30914652 | ||
| Pubmed | β-Catenin is critical for cerebellar foliation and lamination. | 2.05e-04 | 8 | 95 | 2 | 23691221 | |
| Pubmed | 2.05e-04 | 8 | 95 | 2 | 23516305 | ||
| Pubmed | Atad3 function is essential for early post-implantation development in the mouse. | 2.05e-04 | 8 | 95 | 2 | 23372768 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TTF2 ATAD3B RBFOX3 COPA TTC28 ATAD3A SYNE1 MRPL44 PPA2 MTR TTC17 ST13 PRRC2B | 2.15e-04 | 1496 | 95 | 13 | 32877691 |
| Pubmed | COL5A1 MYOF MISP EPS8L2 COPA CALR PPA2 TTC17 ST13P5 ALDH7A1 PRRC2B PNPO | 2.17e-04 | 1297 | 95 | 12 | 33545068 | |
| Pubmed | Absence of LPA1 signaling results in defective cortical development. | 2.62e-04 | 9 | 95 | 2 | 17656621 | |
| Pubmed | Activation of TrkB signaling mitigates cerebellar anomalies caused by Rbm4-Bdnf deficiency. | 2.62e-04 | 9 | 95 | 2 | 37670183 | |
| Cytoband | 9q21.11 | 4.34e-07 | 30 | 94 | 4 | 9q21.11 | |
| Cytoband | 15q25.2 | 9.67e-05 | 43 | 94 | 3 | 15q25.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q25 | 3.39e-04 | 160 | 94 | 4 | chr15q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q21 | 7.70e-04 | 199 | 94 | 4 | chr9q21 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.79e-08 | 161 | 57 | 8 | 593 | |
| GeneFamily | Forkhead boxes | 1.00e-05 | 43 | 57 | 4 | 508 | |
| GeneFamily | Fibronectin type III domain containing | 1.09e-05 | 160 | 57 | 6 | 555 | |
| GeneFamily | Immunoglobulin like domain containing | 3.20e-03 | 193 | 57 | 4 | 594 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.04e-03 | 206 | 57 | 4 | 682 | |
| Coexpression | MORI_MATURE_B_LYMPHOCYTE_UP | 1.03e-07 | 106 | 93 | 7 | MM595 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-Lymphoid_DC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.95e-08 | 168 | 94 | 7 | 6dd58fd981750da49afd53796f244e1803cce97f | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-07 | 193 | 94 | 7 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.20e-07 | 199 | 94 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.28e-07 | 200 | 94 | 7 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.28e-07 | 200 | 94 | 7 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.28e-07 | 200 | 94 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-aDC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.08e-06 | 177 | 94 | 6 | ccf5dc54780d6039a4d062dee88440c011ddc0a3 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.15e-06 | 178 | 94 | 6 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-06 | 179 | 94 | 6 | a09647750eba9d93c5efc1db3b555fefb5eec7b5 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.37e-06 | 181 | 94 | 6 | bec917f6f56ae252639a5a76024be5df5c70a6d5 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.60e-06 | 184 | 94 | 6 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.60e-06 | 184 | 94 | 6 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.60e-06 | 184 | 94 | 6 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.23e-06 | 191 | 94 | 6 | 27a532a35d9e8822014f581fd56c4ca62e39f8fe | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.23e-06 | 191 | 94 | 6 | 1dfcff08e01e6a695953334342bcfde04ba005ad | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.43e-06 | 193 | 94 | 6 | 32eb026d4317c1499d51294d396dfd5f293f9deb | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 193 | 94 | 6 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.43e-06 | 193 | 94 | 6 | 930df79b0600f43617052313294be33bcf5631f0 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-06 | 194 | 94 | 6 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.86e-06 | 197 | 94 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.86e-06 | 197 | 94 | 6 | a6a27e5809ee2c9b56c7e06c35e4f140f9fa13ad | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.97e-06 | 198 | 94 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.97e-06 | 198 | 94 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.09e-06 | 199 | 94 | 6 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.09e-06 | 199 | 94 | 6 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-06 | 199 | 94 | 6 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.09e-06 | 199 | 94 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.09e-06 | 199 | 94 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.09e-06 | 199 | 94 | 6 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.09e-06 | 199 | 94 | 6 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.21e-06 | 200 | 94 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.21e-06 | 200 | 94 | 6 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.21e-06 | 200 | 94 | 6 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 4.21e-06 | 200 | 94 | 6 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 8.64e-06 | 131 | 94 | 5 | ff4e618bd944f852bbd34438f740187aca82460f | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.79e-05 | 167 | 94 | 5 | 720dc5855c856b478b5ca90156b30bfcc5518d60 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 3.21e-05 | 172 | 94 | 5 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | wk_20-22-Hematologic-Myeloid-aDC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.78e-05 | 178 | 94 | 5 | fd2bdb4796e86c8cff2d25f0c730ffea21db8787 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.99e-05 | 180 | 94 | 5 | 32d871738a24071b70084a7e80148a516110c78b | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.99e-05 | 180 | 94 | 5 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.99e-05 | 180 | 94 | 5 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.99e-05 | 180 | 94 | 5 | 067ca8a15228c7f3b3bc7aecbc9b1611ca05e176 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.99e-05 | 180 | 94 | 5 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.20e-05 | 182 | 94 | 5 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.20e-05 | 182 | 94 | 5 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.32e-05 | 183 | 94 | 5 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 186 | 94 | 5 | 5d0cd07b6b51e8ce9e1da949f757dc4575ec5752 | |
| ToppCell | facs-BAT-Fat-24m-Epithelial-Epcam+|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 186 | 94 | 5 | b18d7398279a2d42414318aeb70514fd402f5a0a | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.78e-05 | 187 | 94 | 5 | 7170694a1b86fe8d84d96c880ffe57af09bdc026 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.78e-05 | 187 | 94 | 5 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.91e-05 | 188 | 94 | 5 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.91e-05 | 188 | 94 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 189 | 94 | 5 | a9864873b19ab3e60acf11f288fa7275badc2e42 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.03e-05 | 189 | 94 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-05 | 190 | 94 | 5 | 47e07ea22733306d8885ee9e5f0b033e2f5e2afb | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-05 | 190 | 94 | 5 | 261b8afddfdcba4f70b50df126cef7ad00a0aae0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.16e-05 | 190 | 94 | 5 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.16e-05 | 190 | 94 | 5 | ab56800abd1d5cbe2351834a1df749ac7db30892 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.29e-05 | 191 | 94 | 5 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-05 | 192 | 94 | 5 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.42e-05 | 192 | 94 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.42e-05 | 192 | 94 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.42e-05 | 192 | 94 | 5 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.69e-05 | 194 | 94 | 5 | 07d8e38cbc2c7f0564c14f7c365f345f901b73b2 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.69e-05 | 194 | 94 | 5 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.69e-05 | 194 | 94 | 5 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-05 | 194 | 94 | 5 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.69e-05 | 194 | 94 | 5 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.69e-05 | 194 | 94 | 5 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.69e-05 | 194 | 94 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-05 | 194 | 94 | 5 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.69e-05 | 194 | 94 | 5 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | normal_Lung-Epithelial_cells-AT1|normal_Lung / Location, Cell class and cell subclass | 5.83e-05 | 195 | 94 | 5 | 569d1ebc5a5aa110a2430b096755ae35354040c4 | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 196 | 94 | 5 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.98e-05 | 196 | 94 | 5 | cf7f384c1771274e766bab03ecc3dfbd13f2df60 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.98e-05 | 196 | 94 | 5 | 27a216af92100224818c91e298428bee25ab0af8 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 196 | 94 | 5 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 6.12e-05 | 197 | 94 | 5 | 8545baf923ddf84c5ce9414a36d810603be52401 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.12e-05 | 197 | 94 | 5 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | VE-CD8-proli_CD4|VE / Condition, Cell_class and T cell subcluster | 6.25e-05 | 101 | 94 | 4 | 5293f15b5ed340e6d0282b56de13752eabeef8dd | |
| ToppCell | 15-Distal-Epithelial-Bud_tip_adjacent|Distal / Age, Tissue, Lineage and Cell class | 6.27e-05 | 198 | 94 | 5 | f4d9d5995a42f71bf412f0ad299fc963bad3a898 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.27e-05 | 198 | 94 | 5 | 1fbec311f2c987ca90a023a5989128c05aa12d5c | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.27e-05 | 198 | 94 | 5 | 4f26a60e99f42343e5af7221723e108a1a1b7827 | |
| ToppCell | Control_saline-Epithelial_alveolar|Control_saline / Treatment groups by lineage, cell group, cell type | 6.27e-05 | 198 | 94 | 5 | 532b7ef4ad46fe35ad2c6bdf89f70a17f1a2e2e2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.42e-05 | 199 | 94 | 5 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.42e-05 | 199 | 94 | 5 | c1daa481f88d5281b6b5ea8ec8bb70cc0907d613 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.42e-05 | 199 | 94 | 5 | 9735a1dc10910f02f1106b20ae5ab4c09c21305e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.42e-05 | 199 | 94 | 5 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.42e-05 | 199 | 94 | 5 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.58e-05 | 200 | 94 | 5 | 7547d6339f9380d031cfd2cce21ac9a12491e085 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Macroglial-Astrocyte|2m / Sample Type, Dataset, Time_group, and Cell type. | 6.58e-05 | 200 | 94 | 5 | 4cf46f1e362da4ef7399b01b28c011f0b3bd2815 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Glia_progenitor_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 6.58e-05 | 200 | 94 | 5 | 4b937b1d0179d1d0e51931f35720e205d460a07e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.58e-05 | 200 | 94 | 5 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Cytl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.00e-05 | 104 | 94 | 4 | 5d9cd14e53a2f1060e528abf6c0694be9d72c356 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.03e-04 | 137 | 94 | 4 | 306b11b3b9e5fd562d845fb5eaa4ac982864efce | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.03e-04 | 137 | 94 | 4 | d37f425b13bc046baa1f8619b98a16b936f88ff6 | |
| Drug | Condelphine [7633-69-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.06e-06 | 197 | 89 | 8 | 3538_DN | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.10e-06 | 198 | 89 | 8 | 5479_UP | |
| Drug | Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; PC3; HT_HG-U133A | 1.08e-05 | 193 | 89 | 7 | 3672_DN | |
| Drug | Mesalamine [89-57-6]; Up 200; 26.2uM; PC3; HT_HG-U133A | 1.19e-05 | 196 | 89 | 7 | 5888_UP | |
| Drug | 0316684-0000 [391209-55-5]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.23e-05 | 197 | 89 | 7 | 7052_UP | |
| Drug | Etofylline [519-37-9]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 1.23e-05 | 197 | 89 | 7 | 5467_UP | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.23e-05 | 197 | 89 | 7 | 4501_DN | |
| Drug | Ornidazole [16773-42-5]; Down 200; 18.2uM; MCF7; HT_HG-U133A | 1.28e-05 | 198 | 89 | 7 | 2272_DN | |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 1.28e-05 | 198 | 89 | 7 | 1534_DN | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; PC3; HT_HG-U133A | 1.28e-05 | 198 | 89 | 7 | 3711_DN | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.28e-05 | 198 | 89 | 7 | 6270_UP | |
| Drug | AC1NUZ2Z | 1.61e-05 | 13 | 89 | 3 | CID005464257 | |
| Drug | ethyl bromodifluoroacetate | 4.52e-05 | 3 | 89 | 2 | CID000069585 | |
| Drug | imidazo[1,2-a]pyrazine | 4.52e-05 | 3 | 89 | 2 | CID002771670 | |
| Drug | phosphorus pentachloride | 4.52e-05 | 3 | 89 | 2 | CID000024819 | |
| Drug | pyridazinone | 9.02e-05 | 4 | 89 | 2 | CID000068153 | |
| Drug | SDZ ISQ 844 | 9.02e-05 | 4 | 89 | 2 | CID000132565 | |
| Drug | ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 9.63e-05 | 188 | 89 | 6 | 974_UP | |
| Drug | Ald1.1-H_000455; Up 200; 10uM; MCF7; HT_HG-U133A | 1.05e-04 | 191 | 89 | 6 | 7542_UP | |
| Drug | AC1L1JKL | 1.10e-04 | 24 | 89 | 3 | CID000005082 | |
| Drug | aldophosphamide | 1.10e-04 | 24 | 89 | 3 | CID000107744 | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; PC3; HT_HG-U133A | 1.11e-04 | 193 | 89 | 6 | 5764_DN | |
| Drug | Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.14e-04 | 194 | 89 | 6 | 4219_DN | |
| Drug | Racecadotril [81110-73-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.14e-04 | 194 | 89 | 6 | 5755_DN | |
| Drug | Desipramine hydrochloride [58-28-6]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.18e-04 | 195 | 89 | 6 | 3212_UP | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.21e-04 | 196 | 89 | 6 | 5827_DN | |
| Drug | Flurbiprofen [5104-49-4]; Down 200; 16.4uM; HL60; HT_HG-U133A | 1.21e-04 | 196 | 89 | 6 | 3095_DN | |
| Drug | 0393-0188; Down 200; 10uM; MCF7; HT_HG-U133A | 1.21e-04 | 196 | 89 | 6 | 7531_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.21e-04 | 196 | 89 | 6 | 3816_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 1.21e-04 | 196 | 89 | 6 | 4747_DN | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; HL60; HT_HG-U133A | 1.24e-04 | 197 | 89 | 6 | 3000_UP | |
| Drug | Mometasone furoate [83919-23-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.24e-04 | 197 | 89 | 6 | 5541_UP | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.24e-04 | 197 | 89 | 6 | 3884_DN | |
| Drug | Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.24e-04 | 197 | 89 | 6 | 5752_DN | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 1.24e-04 | 197 | 89 | 6 | 6198_UP | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Up 200; 12.4uM; HL60; HT_HG-U133A | 1.24e-04 | 197 | 89 | 6 | 2991_UP | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 1.24e-04 | 197 | 89 | 6 | 7344_UP | |
| Drug | Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.24e-04 | 197 | 89 | 6 | 2301_DN | |
| Drug | C75; Down 200; 10uM; PC3; HT_HG-U133A | 1.24e-04 | 197 | 89 | 6 | 6428_DN | |
| Drug | Propantheline bromide [50-34-0]; Down 200; 9uM; PC3; HT_HG-U133A | 1.24e-04 | 197 | 89 | 6 | 4214_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.24e-04 | 197 | 89 | 6 | 6180_UP | |
| Drug | Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 1.24e-04 | 197 | 89 | 6 | 7360_UP | |
| Drug | AC1L9IQ6 | 1.25e-04 | 25 | 89 | 3 | CID000445893 | |
| Drug | Aztreonam [78110-38-0]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.28e-04 | 198 | 89 | 6 | 2118_UP | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.28e-04 | 198 | 89 | 6 | 1633_DN | |
| Drug | S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.28e-04 | 198 | 89 | 6 | 6459_DN | |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; HL60; HT_HG-U133A | 1.28e-04 | 198 | 89 | 6 | 2171_UP | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Up 200; 10uM; PC3; HT_HG-U133A | 1.28e-04 | 198 | 89 | 6 | 7381_UP | |
| Drug | Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.28e-04 | 198 | 89 | 6 | 5644_UP | |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 1.28e-04 | 198 | 89 | 6 | 1503_DN | |
| Drug | Betazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A | 1.28e-04 | 198 | 89 | 6 | 5445_DN | |
| Drug | Glibenclamide [10238-21-8]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.28e-04 | 198 | 89 | 6 | 3163_UP | |
| Drug | THIP Hydrochloride; Down 200; 22.6uM; MCF7; HT_HG-U133A | 1.32e-04 | 199 | 89 | 6 | 6511_DN | |
| Drug | Hemicholinium bromide [312-45-8]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.32e-04 | 199 | 89 | 6 | 3216_UP | |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.32e-04 | 199 | 89 | 6 | 3543_DN | |
| Drug | Pizotifen malate [5189-11-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.32e-04 | 199 | 89 | 6 | 6513_DN | |
| Drug | Mesalamine [89-57-6]; Up 200; 26.2uM; MCF7; HT_HG-U133A | 1.32e-04 | 199 | 89 | 6 | 7241_UP | |
| Drug | Propylthiouracil [51-52-5]; Up 200; 23.4uM; PC3; HT_HG-U133A | 1.32e-04 | 199 | 89 | 6 | 4076_UP | |
| Drug | succinonitrile | 1.50e-04 | 5 | 89 | 2 | CID000008062 | |
| Drug | glyphosate | 2.00e-04 | 215 | 89 | 6 | CID000003496 | |
| Disease | aspartate aminotransferase measurement | PCSK1 ABCA1 TTC28 NTRK2 OBSCN DNAH2 SUGP1 CUBN CTSH CNTN2 ALPK2 | 4.54e-05 | 904 | 83 | 11 | EFO_0004736 |
| Disease | neuromuscular disease (implicated_via_orthology) | 4.67e-05 | 4 | 83 | 2 | DOID:440 (implicated_via_orthology) | |
| Disease | vitamin B12 deficiency (biomarker_via_orthology) | 4.67e-05 | 4 | 83 | 2 | DOID:0050731 (biomarker_via_orthology) | |
| Disease | Squamous cell carcinoma of esophagus | 1.52e-04 | 95 | 83 | 4 | C0279626 | |
| Disease | Bleeding tendency | 1.63e-04 | 7 | 83 | 2 | C1458140 | |
| Disease | protein CREG1 measurement | 2.78e-04 | 9 | 83 | 2 | EFO_0801937 | |
| Disease | homocysteine measurement | 2.99e-04 | 46 | 83 | 3 | EFO_0004578 | |
| Disease | Hypertrophic Cardiomyopathy | 5.63e-04 | 57 | 83 | 3 | C0007194 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 5.98e-04 | 13 | 83 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Paranoid Schizophrenia | 5.98e-04 | 13 | 83 | 2 | C0036349 | |
| Disease | Colorectal Carcinoma | 8.10e-04 | 702 | 83 | 8 | C0009402 | |
| Disease | Blood Coagulation Disorders | 9.14e-04 | 16 | 83 | 2 | C0005779 | |
| Disease | Colorectal Neoplasms | 1.12e-03 | 277 | 83 | 5 | C0009404 | |
| Disease | syndrome (implicated_via_orthology) | 1.16e-03 | 18 | 83 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | intellectual disability (implicated_via_orthology) | 1.25e-03 | 75 | 83 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.62e-03 | 301 | 83 | 5 | DOID:684 (is_marker_for) | |
| Disease | Intellectual Disability | 1.65e-03 | 447 | 83 | 6 | C3714756 | |
| Disease | Cerebral Astrocytoma | 2.25e-03 | 25 | 83 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 2.25e-03 | 25 | 83 | 2 | C0750936 | |
| Disease | Pilocytic Astrocytoma | 2.25e-03 | 25 | 83 | 2 | C0334583 | |
| Disease | Astrocytoma | 2.25e-03 | 25 | 83 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 2.25e-03 | 25 | 83 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 2.25e-03 | 25 | 83 | 2 | C0280785 | |
| Disease | Deafness | 2.25e-03 | 25 | 83 | 2 | C0011053 | |
| Disease | Grade I Astrocytoma | 2.25e-03 | 25 | 83 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 2.25e-03 | 25 | 83 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 2.25e-03 | 25 | 83 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 2.25e-03 | 25 | 83 | 2 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 2.43e-03 | 26 | 83 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 2.43e-03 | 26 | 83 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 2.43e-03 | 26 | 83 | 2 | C0334582 | |
| Disease | eye measurement | 2.62e-03 | 27 | 83 | 2 | EFO_0004731 | |
| Disease | Anaplastic astrocytoma | 2.62e-03 | 27 | 83 | 2 | C0334579 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKAYAQIRVGNPWDP | 351 | P49419 | |
| SGQPKPEVTWYKNGQ | 36 | Q86TB3 | |
| GLGDRPAPKDKWSNF | 36 | Q9NVI7 | |
| RGWGQYLFKNKPPDG | 246 | Q9Y297 | |
| TNKIKDGYWDPGPRA | 566 | O95477 | |
| EDGSKGKSAPYQWPS | 151 | Q8N4X5 | |
| RPKENPYLWNKFADG | 526 | O60423 | |
| VKSHWLGPNYTKEGP | 811 | Q01433 | |
| EINPDSAQPYKWRGK | 176 | Q8NFI4 | |
| EINPDSAQPYKWRGK | 176 | P50502 | |
| IVPWLKKYGTNPSNG | 66 | Q13356 | |
| KKTGNPYTNGWKLNP | 181 | A6NFN3 | |
| KLKEYWQRNSPGVPA | 16 | H3BPF8 | |
| SAPPGQRKKEQWYAG | 626 | Q8IVT2 | |
| LKVKWQRPPGNVDSY | 306 | P23467 | |
| KIRDWYQKQGPGPSR | 111 | P08727 | |
| FLKNSPDTNKYEGWP | 196 | Q96BQ1 | |
| WSLPAKYKQLSPNGG | 666 | Q9UPT6 | |
| NGPGLQYKVSWRQKD | 776 | Q92823 | |
| PGKGNYWSLDPASQD | 176 | Q8WXT5 | |
| PGKGNYWSLDPASQD | 176 | Q6VB84 | |
| QWRQPPGKEIYRKSN | 231 | Q9H7Z6 | |
| KVDWYQQRPGKGPRF | 51 | A0A0B4J1Y8 | |
| DGTSPDYKNWKAGQP | 681 | Q5KU26 | |
| SPKGNWIGEAPYKNG | 201 | Q9H0B8 | |
| AGNPQPSYRWFKDGK | 261 | O14511 | |
| AYWQRKSPGIPAGAN | 31 | A6NEY3 | |
| AYWQRKSPGIPAGAN | 31 | A6NEF3 | |
| AYWQRKSPGIPAGAN | 31 | A6NEM1 | |
| AYWQRKSPGIPAGAN | 31 | A6NI86 | |
| AYWQRKSPGIPAGAN | 31 | H0YKK7 | |
| FWGAKPLAGPDQKEA | 316 | Q9HCC8 | |
| QPQKQPAWKTGTYKG | 191 | Q9H0R1 | |
| QDQEVPKPKSWGGYV | 196 | Q9NVS9 | |
| SVWNYKPPADSGGKE | 221 | O75469 | |
| GKSREPWNPCELYQG | 31 | Q30KQ4 | |
| RPGKGNYWSLDPASQ | 171 | Q12950 | |
| AGQKYWGPASPTHKL | 561 | Q9H6S3 | |
| PKPQRYPSREAGAWN | 526 | Q86T90 | |
| RKKYNPPSWEHRGQP | 1071 | O95248 | |
| RWFKGSQELQPGPKY | 2321 | Q5VST9 | |
| YFTKRKWGQHEGPLP | 591 | Q58A45 | |
| KAFGNLRSPGWPDNY | 3401 | O60494 | |
| PGKGSYWAIDTNPKE | 146 | Q9UPW0 | |
| KNGPEQWSKLYPIAN | 11 | P00915 | |
| GYPNRNWKDAGLKNG | 981 | P53621 | |
| GKTGWFPANYAEKIP | 791 | Q15811 | |
| KPRQIDNPDYKGTWI | 276 | P27797 | |
| PKGSKWEVYPAQVQG | 316 | Q96GE4 | |
| PKENPGSWFSEFKRG | 1696 | P20908 | |
| YTLQARTPPAGKWKQ | 641 | Q02246 | |
| YPPSVDWRKKGNFVS | 116 | P09668 | |
| QWRPVAYSQKPGGRE | 281 | Q8WWB7 | |
| YGGQKAKPGDFPWQV | 446 | O00187 | |
| SWGYGKPFEPRSVKN | 721 | Q8IXH8 | |
| RGHKGPVYKVTWNPF | 701 | Q5VTH9 | |
| QAANLGKPYRPWGTE | 286 | Q9Y5J3 | |
| PGKGNYWTLDPNCEK | 191 | Q12951 | |
| KFKEYWQRNRPGVPA | 16 | A8MQT2 | |
| GKAYPSQKPLAAWTR | 4241 | Q9P225 | |
| ASGKPKPSYRWLKNG | 341 | Q9P232 | |
| KQQARPGDGPVIWDY | 66 | Q96HA8 | |
| SLKPHDYPKWEGGVN | 216 | O14832 | |
| GYQPPRLKEKGKWSA | 231 | Q92918 | |
| GFTENRRPWNYSKPK | 306 | Q9H9J2 | |
| KKEGFRSTGQPWQPD | 4736 | Q8NF91 | |
| PYFKTAPDGWKNSVR | 306 | O15353 | |
| PGKGNYWSLDPASQD | 176 | Q5VV16 | |
| PGKGNYWSLDPASQD | 176 | Q3SYB3 | |
| VKGWGPDYPRQSIKE | 506 | Q13485 | |
| VWQLRGKYPNRGFPK | 981 | Q99707 | |
| GPGAAWYPQLQRKKG | 641 | Q86V20 | |
| EFPGDKWNPITGNRK | 966 | Q9ULL8 | |
| NWFRLYKVPDGKPEN | 236 | Q9H2U2 | |
| KNPPQGSYIYQKRWV | 336 | Q96P48 | |
| GLGDRPAPKDKWSNF | 36 | Q5T9A4 | |
| TVKGNPKPALQWFYN | 306 | Q16620 | |
| AGKANRWFGVAPPKS | 11 | Q8IWZ8 | |
| KDYPKNRHPGWSRGS | 281 | Q8NCJ5 | |
| WEGLVYAPPGKEKQR | 471 | Q9Y2W1 | |
| KGSWTGKNRVQNPYS | 261 | Q9Y397 | |
| RKLHGWAPGPDYQKS | 456 | Q5JSZ5 | |
| TPRCGKKPYWNNEEA | 66 | B1AK76 | |
| DKNPAGDYWKKIPGS | 1341 | O15040 | |
| GPQGKKRDYQRLGWP | 886 | Q96AE7 | |
| YSSPPWAGQHNRKGE | 91 | Q5H9I0 | |
| RGYKKKPASTENGQW | 2421 | Q96JG9 | |
| VGEKPYWKDPNNDFR | 71 | Q9BRA2 | |
| LNPKWPKAYFRQGVA | 121 | Q96AY4 | |
| LQDKPYPDWGKSARA | 176 | Q9H0C3 | |
| GQHAGLEKYPIWKAP | 1396 | P31629 | |
| QKGGPLNKEYTNWEA | 276 | Q9UNY4 | |
| KLKEYWQRNSPGVPA | 16 | A6NN73 | |
| QNESRYPGGDWKPAE | 936 | Q9NZM1 | |
| QWSKDYKGPLDPQRV | 931 | Q5VTT5 | |
| EYDPLANNPGWKKNG | 416 | P29120 |